Either the majority of patients do not heal in a few weeks, or we are spending billions of dollars a year on advanced therapeutics that patients don’t need. Which is it? How can we tell?
I should issue a disclaimer that I’m not a rheumatologist and have no special expertise in connective tissue diseases. However, I do have some rules that have stood me in good stead when it comes to patients with mixed connective tissue disease and ischemia.
The NPUAP staging system was already a mess for a host of reasons, so it really could not be made much worse – but this IS worse.
The number of hyperbaric treatments that have been provided to traditional Medicare beneficiaries has plummeted. We are back to 2009 numbers.
What are your thoughts about how we inform patients regarding the use of animal derived products?
How do we “get to” a Stage 4?
Lately I’ve been wondering about a short-term admission for some of these patients with a Foley, diuresis, a high protein diet, bed rest and aggressive use of their pneumatic compression device. I am sure it would work temporarily.